Morning Movers 03/13: (BBX) (MDS) (WOLF) (CKEC) Higher; (CCIX) (COOL) (BCRX) Lower
Tweet
Share
E-mail
Get Alerts BBX Hot Sheet
Join SI Premium – FREE
BankAtlantic Bancorp, Inc. (NYSE: BBX) 91.7% HIGHER; has entered into an amendment to its November 1, 2011 agreement with BB&T Corporation (NYSE: BBT). The core provisions of the original agreement remain unchanged. In connection with the transaction, BB&T will acquire approximately $2.1 billion in loans and approximately $3.3 billion in deposits based on September 30, 2011 balances. BB&T will pay an estimated premium of $301 million to the closing net asset value of BankAtlantic. The premium, which equates to approximately 9% of total deposits at September 30, 2011, is subject to adjustment based on actual non-CD deposit balances at closing, but in no event will exceed $315.9 million. Under the terms of the modified agreement, BB&T will assume BankAtlantic Bancorp’s obligations with respect to its approximately $285 million of outstanding trust preferred securities.
Midas, Inc. (NYSE: MDS) 27.4% HIGHER; TBC Corporation and Midas today announced that they have entered into a definitive merger agreement, pursuant to which TBC will acquire Midas through a cash tender offer at $11.50 per share.
Great Wolf Resorts, Inc. (Nasdaq: WOLF) 22.4% HIGHER; An affiliate of Apollo Global Management, LLC (NYSE: APO) and Great Wolf announced that they have entered into a definitive merger agreement whereby Apollo, a leading global asset manager, will acquire Great Wolf, North America’s largest family of indoor waterpark resorts, for approximately $703 million
Carmike Cinemas, Inc. (NASDAQ: CKEC) 22% HIGHER; reported Q4 EPS of $0.14, $0.09 better than the analyst estimate of $0.05. Revenue for the quarter came in at $120.1 million versus the consensus estimate of $112.2 million.
Coleman Cable, Inc. (NASDAQ: CCIX) 19.5% LOWER; reported Q4 EPS of $0.07, $0.16 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $206.7 million versus the consensus estimate of $204.19 million. Sees Q1 2012 EPS of $0.14-$0.27, versus the consensus of $0.32. Coleman Cable, Inc. sees Q1 2012 revenue of $210-$220 million, versus the consensus of $215 million.
Omeros Corporation (Nasdaq: OMER) 19.5% HIGHER; reports positive data from its Phase 3 clinical trial evaluating OMS302 in patients undergoing intraocular lens replacement surgery. OMS302 met its primary endpoint by demonstrating statistically significant (p<0.00001) maintenance of intraoperative mydriasis (pupil dilation).
Majesco Entertainment Company (NASDAQ: COOL) 11.8% LOWER; reported Q1 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $66.2 million versus the consensus estimate of $54.9 million. Sees FY2012 EPS of $0.25-$0.35, versus the consensus of $0.35. Sees FY2012 revenue of $130-$140 million, versus the consensus of $136.5 million.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) 9.9% LOWER; reports that it will initiate a process at the United States Patent & Trademark Office to correct an apparent error made by the USPTO. Click here to see the full report.
Midas, Inc. (NYSE: MDS) 27.4% HIGHER; TBC Corporation and Midas today announced that they have entered into a definitive merger agreement, pursuant to which TBC will acquire Midas through a cash tender offer at $11.50 per share.
Great Wolf Resorts, Inc. (Nasdaq: WOLF) 22.4% HIGHER; An affiliate of Apollo Global Management, LLC (NYSE: APO) and Great Wolf announced that they have entered into a definitive merger agreement whereby Apollo, a leading global asset manager, will acquire Great Wolf, North America’s largest family of indoor waterpark resorts, for approximately $703 million
Carmike Cinemas, Inc. (NASDAQ: CKEC) 22% HIGHER; reported Q4 EPS of $0.14, $0.09 better than the analyst estimate of $0.05. Revenue for the quarter came in at $120.1 million versus the consensus estimate of $112.2 million.
Coleman Cable, Inc. (NASDAQ: CCIX) 19.5% LOWER; reported Q4 EPS of $0.07, $0.16 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $206.7 million versus the consensus estimate of $204.19 million. Sees Q1 2012 EPS of $0.14-$0.27, versus the consensus of $0.32. Coleman Cable, Inc. sees Q1 2012 revenue of $210-$220 million, versus the consensus of $215 million.
Omeros Corporation (Nasdaq: OMER) 19.5% HIGHER; reports positive data from its Phase 3 clinical trial evaluating OMS302 in patients undergoing intraocular lens replacement surgery. OMS302 met its primary endpoint by demonstrating statistically significant (p<0.00001) maintenance of intraoperative mydriasis (pupil dilation).
Majesco Entertainment Company (NASDAQ: COOL) 11.8% LOWER; reported Q1 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $66.2 million versus the consensus estimate of $54.9 million. Sees FY2012 EPS of $0.25-$0.35, versus the consensus of $0.35. Sees FY2012 revenue of $130-$140 million, versus the consensus of $136.5 million.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) 9.9% LOWER; reports that it will initiate a process at the United States Patent & Trademark Office to correct an apparent error made by the USPTO. Click here to see the full report.
Create E-mail Alert Related Categories
Special ReportsRelated Entities
BB&T Capital Markets, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
